EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies

Anchal Pathak iD, Ajay Kumar Pal iD, Subhadeep Roy iD, Mukesh Nandave iD, Keerti Jain iD

Stem Cells International · 2024-01 · 2024 (1)

DOI: 10.1155/2024/9077926 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells International, online erschienen am 04.01.2024. Verfasst von Anchal Pathak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery and Nanomedicine Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-…. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 238 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Indian Council of Medical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis plays a significant role in the human body, from wound healing to tumor progression. “Angiogenic switch” indicates a time‐restricted event where the imbalance between pro‐ and antiangiogenic factors results in the transition from prevascular hyperplasia to outgrowing vascularized tumor, which eventually leads to the malignant cancer progression. In the last decade, molecular players, i.e., angiogenic biomarkers and underlying molecular pathways involved in tumorigenesis, have been intensely investigated. Disrupting the initiation and halting the progression of angiogenesis by targeting these biomarkers and molecular pathways has been considered as a potential treatment approach for tumor angiogenesis. This review discusses the currently known biomarkers and available antiangiogenic therapies in cancer, i.e., monoclonal antibodies, aptamers, small molecular inhibitors, miRNAs, siRNAs, angiostatin, endostatin, and melatonin analogues, either approved by the U.S. Food and Drug Administration or currently under clinical and preclinical investigations.

Autor:innen und Institutionen

  • Drug Delivery and Nanomedicine Research Laboratory, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Raebareli, Lucknow, India.
  • Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi 110017, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, West Bengal, India.

ORCID-Profile: Anchal Pathak, Ajay Kumar Pal, Subhadeep Roy, Mukesh Nandave, Keerti Jain

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Pathak, A., Pal, A. K., Roy, S., Nandave, M., & Jain, K. (2024). Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies. Stem Cells International, 2024(1). https://doi.org/10.1155/2024/9077926

Vancouver

Pathak A, Pal AK, Roy S, Nandave M, Jain K. Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies. Stem Cells International. 2024;2024(1). doi:10.1155/2024/9077926

BibTeX
@article{Pathak2024,
  author = {Pathak, Anchal and Pal, Ajay Kumar and Roy, Subhadeep and Nandave, Mukesh and Jain, Keerti},
  title = {Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies},
  journal = {Stem Cells International},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/9077926}
}
Kostenlos starten →